risankizumab meaning in French
risankizumab
Examples
- Risankizumab is part of a collaboration between Boehringer Ingelheim and AbbVie.
Risankizumab est un co-développement entre Boehringer Ingelheim et AbbVie. - Risankizumab also known as BI-655066 is a humanized monoclonal antibody targeting interleukin 23A (IL-23A).
Le risankizumab dont le nom codé chez Boehringer Ingelheim est BI-655066 est un anticorps monoclonal humanisé ciblant l'interleukine 23 (IL-23).